Structures by: Vella-Zarb L.
Total: 30
Trans,trans,anti,trans,trans-Perhydropyrene
C16H26
IUCrJ (2019) 6, 1 136-144
a=14.3334(3)Å b=5.56223(10)Å c=8.53021(19)Å
α=90° β=92.0219(15)° γ=90°
Cabazitaxel
C45H57NO14
CrystEngComm (2014) 16, 44 10161
a=8.351(3)Å b=44.438(17)Å c=11.410(4)Å
α=90° β=98.532(5)° γ=90°
Cabazitaxel tetrahydrofurane solvate
C45H57NO14,0.5(C7H14.03O2)
CrystEngComm (2014) 16, 44 10161
a=11.778(5)Å b=17.208(7)Å c=12.339(5)Å
α=90° β=109.747(5)° γ=90°
Cabazitaxel Acetone Solvate
C45H57NO14,C3H6O
CrystEngComm (2014) 16, 44 10161
a=11.725(2)Å b=17.328(3)Å c=12.449(2)Å
α=90° β=110.453(2)° γ=90°
Cabazitaxel hemihydrate
C45H57NO14,0.25(H2O)
CrystEngComm (2014) 16, 44 10161
a=8.506(5)Å b=45.16(2)Å c=11.675(6)Å
α=90° β=98.362(4)° γ=90°
Cabazitaxel ethanol solvate hemihydrate
C45H57NO14,C2H5O,0.5(H2O)
CrystEngComm (2014) 16, 44 10161
a=12.542(2)Å b=8.6716(16)Å c=42.090(8)Å
α=90° β=89.987(2)° γ=90°
Bis-1,2,3-Triamino-2,4,6-triazinium ethylenetriaminetetraacetate diaqua
C10H14N2O8,2(C3H7N6),2(H2O)
CrystEngComm (2014) 16, 35 8147
a=7.0884(3)Å b=7.7150(2)Å c=11.6340(5)Å
α=80.755(3)° β=78.037(4)° γ=83.455(3)°
Melamine DMSO solvate
C3H6N6,C2H6OS
CrystEngComm (2014) 16, 35 8147
a=7.4296(6)Å b=12.3333(11)Å c=11.9384(11)Å
α=90° β=114.070(6)° γ=90°
Dimelaminium sulfate
2(C3H7N6),O4S
CrystEngComm (2014) 16, 35 8147
a=18.041(2)Å b=10.6373(14)Å c=14.289(2)Å
α=90° β=103.652(14)° γ=90°
Melaminium dinitrate
C3H8N6,2(NO3)
CrystEngComm (2014) 16, 35 8147
a=7.7710(14)Å b=9.8924(18)Å c=12.186(2)Å
α=90° β=101.198(9)° γ=90°
Tri-theobromine melamine
C3H6N6,3(C7H8N4O2)
CrystEngComm (2014) 16, 35 8147
a=14.3308(8)Å b=16.2228(10)Å c=13.1104(10)Å
α=90° β=109.388(7)° γ=90°
Dimelaminium sulfate
2(C3H7N6),O4S
CrystEngComm (2014) 16, 35 8147
a=18.041(2)Å b=10.6373(14)Å c=14.289(2)Å
α=90° β=103.652(14)° γ=90°
Melaminium dinitrate
C3H8N6,2(NO3)
CrystEngComm (2014) 16, 35 8147
a=7.7710(14)Å b=9.8924(18)Å c=12.186(2)Å
α=90° β=101.198(9)° γ=90°
Tri-theobromine melamine
C3H6N6,3(C7H8N4O2)
CrystEngComm (2014) 16, 35 8147
a=14.3308(8)Å b=16.2228(10)Å c=13.1104(10)Å
α=90° β=109.388(7)° γ=90°
Bis-1,2,3-Triamino-2,4,6-triazinium ethylenetriaminetetraacetate diaqua
C10H14N2O8,2(C3H7N6),2(H2O)
CrystEngComm (2014) 16, 35 8147
a=7.0884(3)Å b=7.7150(2)Å c=11.6340(5)Å
α=80.755(3)° β=78.037(4)° γ=83.455(3)°
Melamine DMSO solvate
C3H6N6,C2H6OS
CrystEngComm (2014) 16, 35 8147
a=7.4296(6)Å b=12.3333(11)Å c=11.9384(11)Å
α=90° β=114.070(6)° γ=90°
TDIC
C18H12N4O4
Acta Crystallographica Section B (2012) 68, 2 204-208
a=9.09477(8)Å b=7.45366(5)Å c=12.75989(16)Å
α=93.5753(8)° β=99.7115(6)° γ=114.0050(6)°
TDIC
C18H12N4O4
Acta Crystallographica Section B (2012) 68, 2 204-208
a=4.53125(8)Å b=5.99235(8)Å c=14.7567(3)Å
α=88.2562(12)° β=81.6029(15)° γ=81.2337(13)°
5-Methylsalicylaldehyde
C8H8O2
Acta Crystallographica Section E (2017) 73, 2 155-158
a=8.3676(17)Å b=13.088(3)Å c=6.4867(13)Å
α=90° β=106.30(3)° γ=90°
Gallic Acid Tris-Caffeine hexahydrate
C7H6O5,3(C8H10N4O2),6(H2O)
Acta Crystallographica Section E (2018) 74, 4 559-562
a=16.5434(3)Å b=6.79456(11)Å c=18.1390(4)Å
α=90° β=110.865(2)° γ=90°
Docetaxel trihydrate
C43H53NO14,3(H2O)
Crystal Growth & Design (2013) 13, 10 4402
a=8.6619(8)Å b=12.7429(9)Å c=39.838(4)Å
α=90° β=90° γ=90°
Docetaxel monohydrate
C43H53NO14,H2O
Crystal Growth & Design (2013) 13, 10 4402
a=8.625(2)Å b=12.910(2)Å c=39.764(11)Å
α=90° β=90° γ=90°
Docetaxel monohydrate
C43H53NO14
Crystal Growth & Design (2013) 13, 10 4402
a=8.6078(8)Å b=12.9231(16)Å c=38.421(5)Å
α=90° β=90° γ=90°
Docetaxel hydrate ethanol solvate
C43H53NO14,C2H7O2
Crystal Growth & Design (2013) 13, 10 4402
a=12.608(3)Å b=8.6626(19)Å c=20.353(4)Å
α=90° β=98.942(2)° γ=90°
Docetaxel trihydrate
C43H53NO14,3(H2O)
Crystal Growth & Design (2013) 13, 10 4402
a=8.594(2)Å b=12.644(3)Å c=39.717(10)Å
α=90° β=90° γ=90°
Docetaxel dihydrate
C43H53NO14,CH3.5O,H2O
Crystal Growth & Design (2013) 13, 10 4402
a=10.287(2)Å b=32.938(8)Å c=12.780(3)Å
α=90° β=90.213(3)° γ=90°
C12H11ClN2O5S,C12H11ClN2O5S,C6H6N2O
C12H11ClN2O5S,C12H11ClN2O5S,C6H6N2O
Crystal Growth & Design (2014) 14, 2 783
a=5.0178(11)Å b=38.527(8)Å c=17.031(4)Å
α=90° β=94.353(3)° γ=90°
C12H11ClN2O5S,C6H6N2O1
C12H11ClN2O5S,C6H6N2O1
Crystal Growth & Design (2014) 14, 2 783
a=12.8613(15)Å b=5.3305(6)Å c=29.105(3)Å
α=90° β=100.016(2)° γ=90°
C12H11ClN2O5S,C6H6N2O
C12H11ClN2O5S,C6H6N2O
Crystal Growth & Design (2014) 14, 2 783
a=4.8206(3)Å b=20.6135(14)Å c=19.1406(12)Å
α=90° β=93.291(2)° γ=90°
C19H18Cl1N3O7S1
C19H18Cl1N3O7S1
Crystal Growth & Design (2014) 14, 2 783
a=26.823(5)Å b=4.7607(10)Å c=18.427(4)Å
α=90° β=122.37(3)° γ=90°